CI Health Care Giants Covered Call ETF (TSX: FHI)
Assets | 95.67M |
Expense Ratio | 0.83% |
PE Ratio | 24.33 |
Dividend (ttm) | 0.82 |
Dividend Yield | 7.50% |
Ex-Dividend Date | Dec 23, 2024 |
Payout Frequency | Quarterly |
Payout Ratio | n/a |
1-Year Return | -3.38% |
Volume | 22,101 |
Open | 11.21 |
Previous Close | 11.24 |
Day's Range | 11.15 - 11.23 |
52-Week Low | 10.45 |
52-Week High | 12.29 |
Beta | 0.63 |
Holdings | 44 |
Inception Date | Jun 7, 2018 |
About FHI
CI Health Care Giants Covered Call ETF is an exchange traded fund launched and managed by CI Global Asset Management. The fund invests in the public equity markets of the United States and Canada region. It invests directly and through derivatives in stocks of companies operating across health care sector. It uses derivatives such as options to create its portfolio. It invests in growth and value stocks of large-cap companies. The fund seeks to benchmark the performance of its portfolio against the S&P 500 Health Care Index. CI Health Care Giants Covered Call ETF was formed on June 7, 2018 and is domiciled in Canada.
Performance
FHI had a total return of 3.81% in the past year. Since the fund's inception, the average annual return has been 8.80%, including dividends.
Top 10 Holdings
140.22% of assetsName | Symbol | Weight |
---|---|---|
Canadian Dollar | n/a | 94.77% |
UnitedHealth Group Incorporated | UNH | 5.09% |
AbbVie Inc. | ABBV | 5.08% |
Pfizer Inc. | PFE | 5.07% |
Merck & Co., Inc. | MRK | 5.05% |
Eli Lilly and Company | LLY | 5.04% |
Johnson & Johnson | JNJ | 5.04% |
Bristol-Myers Squibb Company | BMY | 5.03% |
Danaher Corporation | DHR | 5.02% |
Gilead Sciences, Inc. | GILD | 5.02% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 23, 2024 | 0.2115 CAD | Dec 31, 2024 |
Sep 23, 2024 | 0.2304 CAD | Sep 27, 2024 |
Jun 24, 2024 | 0.196 CAD | Jun 28, 2024 |
Mar 21, 2024 | 0.185 CAD | Mar 28, 2024 |
Dec 20, 2023 | 0.193 CAD | Dec 29, 2023 |
Sep 22, 2023 | 0.1966 CAD | Sep 29, 2023 |